This study, using both genetic disruption and pharmacological inhibition approaches, demonstrated that AT2 receptor deficiency did not influence AngII-induced AAAs, TAAs, and atherosclerosis in hypercholesterolemic mice. Here, AGTR2 is linked to atherosclerosis.